id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-269151-r426u5dz	Turner, Jeffrey M.	Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension?	2020-07-09		.txt	text/plain	4595	212	42	More recently, a number of indirect comparisons with pooled analysis of several randomized placebo control trials have been done to further elucidate whether ACE inhibitors and ARBs have differing effects on the risk of myocardial infarction [16] [17] [18] [19] . Finally, in the previously mentioned Bangalore paper, a separate meta-analysis of the only head to head trials between ACE inhibitors and ARBs also showed no difference in the risk for myocardial infarction or cardiovascular death between the two classes [16] . Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers have resulted in significant improvements in outcomes related to congestive heart failure, cardiovascular disease, diabetes, stroke, and kidney disease. A meta-analysis reporting effects of angiotensinconverting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis	./cache/cord-269151-r426u5dz.txt	./txt/cord-269151-r426u5dz.txt